This is a Validated Antibody Database (VAD) review about mouse Prf1, based on 30 published articles (read how Labome selects the articles), using Prf1 antibody in all methods. It is aimed to help Labome visitors find the most suited Prf1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Prf1 synonym: Pfn; Pfp; Prf-1

Invitrogen
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; fig 2m
Invitrogen Prf1 antibody (eBioscience, eBioOMAKD) was used in flow cytometry on mouse samples (fig 2m). Mol Cancer (2021) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; 1:100; loading ...; fig s4b
Invitrogen Prf1 antibody (eBioscience, 12-9392-82) was used in flow cytometry on mouse samples at 1:100 (fig s4b). iScience (2021) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; 1:100; loading ...; fig s8e
Invitrogen Prf1 antibody (Thermo Fisher Scientific, 17-9392-80) was used in flow cytometry on mouse samples at 1:100 (fig s8e). Nat Commun (2021) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; loading ...; fig 6g
Invitrogen Prf1 antibody (eBioscience, 17-9392-80) was used in flow cytometry on mouse samples (fig 6g). Signal Transduct Target Ther (2021) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; 1:50; loading ...
Invitrogen Prf1 antibody (Thermo Fisher Scientific, eBioOMAK-D) was used in flow cytometry on mouse samples at 1:50. elife (2020) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; 1:100; loading ...; fig 2i
Invitrogen Prf1 antibody (eBioscience, 17-9392-80) was used in flow cytometry on mouse samples at 1:100 (fig 2i). EMBO Mol Med (2020) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; 1:50; fig 5f
Invitrogen Prf1 antibody (eBioscience, 17-9392-80) was used in flow cytometry on mouse samples at 1:50 (fig 5f). Nat Commun (2019) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; 1:66; loading ...; fig 2c
Invitrogen Prf1 antibody (eBioscience, 12-9392-82) was used in flow cytometry on mouse samples at 1:66 (fig 2c). Nat Commun (2018) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; loading ...; fig ex7g
Invitrogen Prf1 antibody (eBioscience, 17-9392-80) was used in flow cytometry on mouse samples (fig ex7g). Nature (2018) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; loading ...; fig 6d
Invitrogen Prf1 antibody (eBioscience, 17-9392-80) was used in flow cytometry on mouse samples (fig 6d). Nat Commun (2018) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; loading ...; fig 5c
Invitrogen Prf1 antibody (eBiosciences, eBioOMAK-D) was used in flow cytometry on mouse samples (fig 5c). Cell Immunol (2018) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; loading ...
In order to evaluate mouse models of hepacivirus infection, Invitrogen Prf1 antibody (eBioscience, eBioOMAN-D) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; loading ...; fig 4j
In order to study the role of MYSM1 in T cell development, Invitrogen Prf1 antibody (eBioscience, eBioOMAK-D) was used in flow cytometry on mouse samples (fig 4j). Immunology (2017) ncbi
rat monoclonal (eBioOMAK-D)
In order to discuss the contribution of astrocytic IL-15 to postischemic brain damage, Invitrogen Prf1 antibody (ebioscience, eBioOMAK-D) was used . Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; 1:50; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, Invitrogen Prf1 antibody (eBioscience, eBioOMAK-D) was used in flow cytometry on mouse samples at 1:50 (tbl s2). Nat Immunol (2016) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; fig 3a
In order to study mTOR signaling in gamma delta T cells, Invitrogen Prf1 antibody (eBioscience, OMAK-D) was used in flow cytometry on mouse samples (fig 3a). J Leukoc Biol (2016) ncbi
domestic rabbit polyclonal
In order to assess the reactivity of perforin and alpha-actin on uterine natural killer cell from LPS-treated pregnant mice, Invitrogen Prf1 antibody (Thermo Fisher Scientific In, PA1-22489) was used . Physiol Res (2015) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse
Invitrogen Prf1 antibody (ebioscience, eBioOMAK-D) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse
In order to characterize a Vi-positive S. Typhimurium with the Salmonella pathogenicity island-7, Invitrogen Prf1 antibody (eBioscience, eBioOMAK-D) was used in flow cytometry on mouse samples . PLoS Pathog (2011) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; fig 3
In order to study the role of liver NK cells in virus-induced severe viral hepatitis, Invitrogen Prf1 antibody (eBioscience, eBioOMAK-D) was used in flow cytometry on mouse samples (fig 3). J Immunol (2010) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse
In order to assess the role of T regulatory cells in Th2-type airway inflammation in mice, Invitrogen Prf1 antibody (eBioscience, eBioOMAK-D) was used in flow cytometry on mouse samples . J Immunol (2008) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; fig 3
Invitrogen Prf1 antibody (eBioscience, eBioMAK-D) was used in flow cytometry on mouse samples (fig 3). J Immunol (2007) ncbi
rat monoclonal (eBioOMAK-D)
  • flow cytometry; mouse; fig 7
In order to elucidate CTLA-4 regulation of cytotoxic T lymphocytes in a transgenic model of CD8+ T-cell-mediated myocarditis, Invitrogen Prf1 antibody (Ebiosciences, eBioOMAK-D) was used in flow cytometry on mouse samples (fig 7). Circ Res (2007) ncbi
BioLegend
rat monoclonal (S16009A)
  • flow cytometry; mouse; loading ...; fig s3
BioLegend Prf1 antibody (BioLegend, 154303) was used in flow cytometry on mouse samples (fig s3). Cell Rep (2022) ncbi
rat monoclonal (S16009A)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend Prf1 antibody (BioLegend, S16009A) was used in flow cytometry on mouse samples (fig s5b). Commun Biol (2021) ncbi
rat monoclonal (S16009A)
  • flow cytometry; mouse; 1:500; loading ...; fig 7f
BioLegend Prf1 antibody (BioLegend, S16009A) was used in flow cytometry on mouse samples at 1:500 (fig 7f). Sci Adv (2021) ncbi
rat monoclonal (S16009B)
  • flow cytometry; mouse; loading ...; fig s4c
BioLegend Prf1 antibody (Biolegend, 154406) was used in flow cytometry on mouse samples (fig s4c). JCI Insight (2021) ncbi
rat monoclonal (S16009A)
  • flow cytometry; mouse; loading ...; fig 7a
BioLegend Prf1 antibody (BioLegend, 154303) was used in flow cytometry on mouse samples (fig 7a). Neoplasia (2021) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-2)
  • western blot; human; 1:250; fig 5c
Santa Cruz Biotechnology Prf1 antibody (Santa Cruz, sc-373943) was used in western blot on human samples at 1:250 (fig 5c). J Extracell Vesicles (2017) ncbi
mouse monoclonal (E-5)
  • immunohistochemistry; human
Santa Cruz Biotechnology Prf1 antibody (Santa Cruz, sc-374346) was used in immunohistochemistry on human samples . Clin Cancer Res (2013) ncbi
Articles Reviewed
  1. Saxena V, Piao W, Li L, Paluskievicz C, Xiong Y, Simon T, et al. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Rep. 2022;39:110727 pubmed publisher
  2. Susukida T, Kuwahara S, Song B, Kazaoka A, Aoki S, Ito K. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity. Commun Biol. 2021;4:1137 pubmed publisher
  3. Rizvi Z, Dalal R, Sadhu S, Kumar Y, Kumar S, Gupta S, et al. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Sci Adv. 2021;7:eabg5016 pubmed publisher
  4. Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20:105 pubmed publisher
  5. Souza C, Ketelut Carneiro N, Milanezi C, Faccioli L, Gardinassi L, Silva J. NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8+ T cell responses. iScience. 2021;24:102548 pubmed publisher
  6. Lin Q, Rong L, Jia X, Li R, Yu B, Hu J, et al. IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun. 2021;12:2537 pubmed publisher
  7. Shen T, Liu J, Wang C, Rixiati Y, Li S, Cai L, et al. Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer. Signal Transduct Target Ther. 2021;6:115 pubmed publisher
  8. Xiao Y, Shu L, Wu X, Liu Y, Cheong L, Liao B, et al. Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages. JCI Insight. 2021;6: pubmed publisher
  9. Wang F, Ye W, Wang S, He Y, Zhong H, Wang Y, et al. Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy. Neoplasia. 2021;23:281-293 pubmed publisher
  10. Piersma S, Poursine Laurent J, Yang L, Barber G, Parikh B, Yokoyama W. Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING. elife. 2020;9: pubmed publisher
  11. Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, et al. Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. EMBO Mol Med. 2020;12:e11571 pubmed publisher
  12. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  13. Wang F, Meng M, Mo B, Yang Y, Ji Y, Huang P, et al. Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function. Nat Commun. 2018;9:4874 pubmed publisher
  14. Song M, Sandoval T, Chae C, Chopra S, Tan C, Rutkowski M, et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423-428 pubmed publisher
  15. Anker J, Naseem A, Mok H, Schaeffer A, Abdulkadir S, Thumbikat P. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat Commun. 2018;9:1591 pubmed publisher
  16. Xiao F, Ai G, Yan W, Wan X, Luo X, Ning Q. Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression. Cell Immunol. 2018;327:13-20 pubmed publisher
  17. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  18. Jong A, Wu C, Li J, Sun J, Fabbri M, Wayne A, et al. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. J Extracell Vesicles. 2017;6:1294368 pubmed publisher
  19. Förster M, Boora R, Petrov J, Fodil N, Albanese I, Kim J, et al. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8+ T cells. Immunology. 2017;151:110-121 pubmed publisher
  20. Li M, Li Z, Yao Y, Jin W, Wood K, Liu Q, et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A. 2017;114:E396-E405 pubmed publisher
  21. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  22. Cao G, Wang Q, Li G, Meng Z, Liu H, Tong J, et al. mTOR inhibition potentiates cytotoxicity of V?4 ?? T cells via up-regulating NKG2D and TNF-?. J Leukoc Biol. 2016;100:1181-1189 pubmed
  23. Zavan B, do Amarante Paffaro A, Paffaro V. alpha-actin down regulation and perforin loss in uterine natural killer cells from LPS-treated pregnant mice. Physiol Res. 2015;64:427-32 pubmed
  24. Murphy K, Erickson J, Johnson C, Seiler C, Bedi J, Hu P, et al. CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma. J Immunol. 2014;192:224-33 pubmed publisher
  25. Frederick D, Piris A, Cogdill A, Cooper Z, Lezcano C, Ferrone C, et al. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013;19:1225-31 pubmed publisher
  26. Jansen A, Hall L, Clare S, Goulding D, Holt K, Grant A, et al. A Salmonella Typhimurium-Typhi genomic chimera: a model to study Vi polysaccharide capsule function in vivo. PLoS Pathog. 2011;7:e1002131 pubmed publisher
  27. Zou Y, Chen T, Han M, Wang H, Yan W, Song G, et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;184:466-75 pubmed publisher
  28. Saito K, Torii M, Ma N, Tsuchiya T, Wang L, Hori T, et al. Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J Immunol. 2008;181:6889-97 pubmed
  29. Badovinac V, Harty J. Manipulating the rate of memory CD8+ T cell generation after acute infection. J Immunol. 2007;179:53-63 pubmed
  30. Love V, Grabie N, Duramad P, Stavrakis G, Sharpe A, Lichtman A. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Circ Res. 2007;101:248-57 pubmed